Interferon-γ enhances susceptibility of cervical cancer cells to lysis by tumor-specific cytotoxic T cells

Gynecologic Oncology

Volumn 65, Issue 2, 1997, Pages 265-272

  Street, Daron ^a   Kaufmann, Andreas M ^a   Vaughan, Andrew ^a   Fisher, Susan G ^a   Hunter, Michael ^a   Schreckenberger, Carola ^a   Potkul, Ronald K ^a   Gissmann, Lutz ^a   Qiao, Liang ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ANTIGEN SPECIFICITY; ARTICLE; CANCER IMMUNOTHERAPY; CELL SPECIFICITY; CYTOTOXIC T LYMPHOCYTE; FEMALE; HUMAN; HUMAN CELL; IMMUNOMODULATION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; UTERINE CERVIX CANCER;

EID: 0031149531     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1997.4667     Document Type: Article

References (25)

1. Shiloni E, Karp S E, Custer M C, Shilyanski J, Restifo N P, Rosenberg S A, Mulé J J. Retroviral transduction of interferon-γ cDNA into a nonimmunogenic murine fibrosarcoma: generation of T cells in draining lymph nodes capable of treating established parental metastatic tumor. Cancer Immunol Immunother. 37:1993;286-292.
2. Bruggen P, van der Traversari C, Chomez P, Lurquin C, De Plaen E, Van den Eynde B, Knuth A, Boon T. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science. 254:1991;1643-1647.
3. Greenberg P D. Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells. Adv Immunol. 49:1991;281-355.
4. Rosenberg S A, Packard B S, Aebersold P M, Dolomon D, Topalian S L, Toy S T, Simon P, Lotze M T, Yang J C, Seipp C A, Simpson C, Carter C, Bock S, Schwarzentruber D, Wei J P, White D E. Use of tumor infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. N Engl J Med. 319:1988;1676-1680.
5. Schreiber H, Ward P L, Rowley D A, Strauss H J. Unique tumor-specific antigens. Annu Rev Immunol. 6:1988;465-483.
6. Van der Eynde B, Lethé B, Van Pel A, De Plaen E, Boon T. The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice. J Exp Med. 173:1991;1373-1384.
7. Chen L, Ashe S, Brady W A, Hellstrom I, Ledbetter J A, McGoan P, Linsley P S. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell. 71:1992;1093-1102.
8. Harding F A, Allison J P. CD28-B7 interaction allow the induction of CD8+ cytotoxic T lymphocytes in the absence of exogenous help. J Exp Med. 177:1993;1791-1796.
9. Kaufmann A M, Gissmann L, Street D, Schreckenberger C, Hunter M, Qiao L. Expression of CD80 enhances immunogenicity of cervical cancer cells in vitro. Cell Immunol. 169:1996;246-251.
10. Makgoba M W, Sanders M E, Luce G EG, Gugel E A, Dustin M L, Springer T A, Shaw S. Functional evidence that intercellular adhesion molecule-1 (ICAM-1) is a ligand for LFA-1-dependent adhesion in T cell-mediated cytotoxicity. Eur J Immunol. 18:1988;637-640.
11. Schirren C A, Volpel H, Meuer S C. Adhesion molecules on freshly recovered T leukemias promote tumor-directed lympholysis. Blood. 79:1992;138-143.
12. Elliott B E, Carlow D A, Rodricks A M, Wade A. Perspectives on the role of MHC antigens in normal and malignant cell development. Adv Cancer Res. 53:1989;181-245.
13. Connor M E, Stern P L. Loss of MHC-class I expression in cervical carcinomas. Int J Cancer. 46:1990;1029-1034.
14. Perez M, Cabrera T, Lopez-Nevot M A, Gomez M, Peran F, Ruiz-Cabello F, Garrido F. Heterogeneity of the expression of class I and class II HLA antigens in human breast carcinoma. J Immunogenet. 13:1986;247-253.
15. Guadagni F, Witt P L, Robbins P F, Schlom J, Greiner J W. Regulation of carcinoembryonic antigen expression in different human colorectal tumor cells by interferon-γ Cancer Res. 50:1990;6248-6255.
16. Kuhn J A, Wong J YC, Beatty B G, Esteban J M, Williams L E, Beatty J D. γ-Interferon enhancement of carcinoembryonic antigen expression in human colon carcinoma xenografts. J Immunother. 11:1992;257-266.
17. Yan X, Wong J YC, Esteban J M, Kuhn J A, Beatty B G, Beatty D, Shively J E. Effects of recombinant human γ-interferon on carcinoembryonic antigen expression of human colon cancer cells. J Immunother. 11:1992;77-84.
18. Dustin M L, Singer K H, Tuck D T, Springer T A. Adhesion of lymphoblasts to epidermal keratinocytes is regulated by interferon-gamma and is mediated by intercellular adhesion molecule 1 (ICAM-1). J Exp Med. 167:1988;1323-1340.
19. von Knebel-Doeberitz M, Oltersdorf T, Schwarz E, Gissmann L. Correlation of modified human papilloma virus early gene expression with altered growth properties in C4-1 cervical carcinoma cells. Cancer Res. 48:1988;3780-3786.
20. Nicoletti I, Migliorati G, Pagliacci M C, Gignanni F, Riccardi C.-A. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods. 139:1991;271-279.
21. Saito T, Berens M, Welander C E. Direct and indirect effects of human recombinant γ-interferon on tumor cells in a clonogenic assay. Cancer Res. 46:1986;1142-1147.
22. Iwasaka T, Hara K, Hayashi Y, Yokoyama M, Hachisuga T, Fukuda K, Okuma Y, Sugimori H. Antitumor effects of human recombinant interferon-γ and tumor necrosis factor on five cervical adenocarcinoma cell lines, in vivo and in vitro. Gynecol Oncol. 42:1991;39-43.
23. Weller M, Frei K, Groscurth P, Krammer P H, Yonekawa Y, Fontana A. Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. J Clin Invest. 94:1994;954-964.
24. de Fougerolles A R, Stacker S A, Schwarting R, Springer T A. Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1. J Exp Med. 174:1991;253-267.
25. de Fougerolles A R, Springer T A. Intercellular adhesion molecule 3, a third adhesion counter-receptor for lymphocyte function-associated molecule 1 on resting lymphocytes. J Exp Med. 175:1992;185-190.